Qiagen (QGEN) Net Income towards Common Stockholders (2009 - 2025)
Qiagen (QGEN) posted Net Income towards Common Stockholders of $522.0 million for Q4 2025, up 301.41% sequentially from $130.0 million in Q3 2025, and up 6.31% YoY from $491.0 million in Q4 2024.
Qiagen (QGEN) Net Income towards Common Stockholders (2009 - 2025) Analysis & Trends
Qiagen has reported Net Income towards Common Stockholders for 17 years, with the latest figure at $522.0 million in Q4 2025.
- Quarterly Net Income towards Common Stockholders rose 6.31% year-over-year to $522.0 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $784.0 million (down 5.88% YoY) and the FY2025 annual result came in at $522.0 million, up 6.31% from the prior year.
- Net Income towards Common Stockholders improved to $522.0 million in Q4 2025 per QGEN's latest filing, from $130.0 million in the prior quarter.
- Over five years, Net Income towards Common Stockholders peaked at $614.0 million in Q4 2021 and troughed at $77.8 million in Q3 2023.
- A 5-year average of $203.7 million and a median of $123.0 million in 2024 frame the typical range for Net Income towards Common Stockholders.
- The sharpest annual moves came in 2022 and 2023: Net Income towards Common Stockholders tumbled 80.13% in 2022, then jumped 290.98% in 2023.
- Over 5 years, Net Income towards Common Stockholders stood at $614.0 million in 2021, then sank by 80.13% to $122.0 million in 2022, then surged by 290.98% to $477.0 million in 2023, then increased by 2.94% to $491.0 million in 2024, then gained by 6.31% to $522.0 million in 2025.
- According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered $522.0 million, $130.0 million, and $132.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 1.76 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 870.00 Mn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -66.93 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 339.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 241.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 338.41 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 207.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 232.90 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 299.10 Mn |
| 10 | Qiagen | 9.49 Bn | 8.72 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 522.00 Mn |
| Sep 30, 2025 | 130.04 Mn |
| Jun 30, 2025 | 132.00 Mn |
| Mar 31, 2025 | 121.00 Mn |
| Dec 31, 2024 | 491.00 Mn |
| Sep 30, 2024 | 98.06 Mn |
| Jun 30, 2024 | 123.00 Mn |
| Mar 31, 2024 | 104.00 Mn |
| Dec 31, 2023 | 477.00 Mn |
| Sep 30, 2023 | 77.82 Mn |
| Jun 30, 2023 | 80.79 Mn |
| Mar 31, 2023 | 85.04 Mn |
| Dec 31, 2022 | 122.00 Mn |
| Jun 30, 2022 | 118.00 Mn |
| Mar 31, 2022 | 184.00 Mn |
| Dec 31, 2021 | 614.00 Mn |
| Jun 30, 2021 | 155.00 Mn |
| Mar 31, 2021 | 154.00 Mn |
| Dec 31, 2020 | 212.69 Mn |
| Sep 30, 2020 | 136.00 Mn |